Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

B cells can both help and hinder the body's defense against melanoma.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

PBMCsec can help reduce and improve thick skin scars.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

AQB reduces harmful skin changes in systemic sclerosis.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Rituximab can cause skin issues, but baricitinib may help improve them.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.